SCHEMBL22821067

SCHEMBL22821067

CC(C)(C)OC(=O)N1CCc2cc(-c3cccc(Br)c3Cl)ccc2C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 4/20 0.60
▸ NR1H2 P55055 1/20 0.51
▸ NAMPT P43490 1/20 0.43
▸ UCHL1 P09936 1/20 0.42
▸ ABHD6 Q9BV23 3/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HDAC1 Q13547 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ PTK2 Q05397 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ CREBBP Q92793 1/20 0.39
▸ ESR1 P03372 3/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ PARP1 P09874 1/20 0.38
▸ TNKS2 Q9H2K2 1/20 0.38
▸ PARP2 Q9UGN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24842903 0.92 ESR2 (0.65) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL29733605 0.89 ESR2 (0.58) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL22821061 0.89 ESR2 (0.58) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL22821052 0.88 ESR2 (0.57) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL24842639 0.87 NR1H2 (0.61) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL22821173 0.87 ESR2 (0.56) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL22820951 0.85 ESR2 (0.54) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL24843624 0.82 ESR2 (0.51) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL22821171 0.82 ESR2 (0.63) ESR2NR1H2NAMPTUCHL1ABHD6
SCHEMBL25407478 0.81 ESR2 (0.60) ESR2NR1H2NAMPTUCHL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257549-A2 COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX, INC. (US) 2020-12-24 — — WO disclosed
Send feedback